"10.1371_journal.pone.0052442","plos one","2013-01-02T00:00:00Z","Caterina Vacchi-Suzzi; Florian Hahne; Philippe Scheubel; Magali Marcellin; Valerie Dubost; Magdalena Westphal; Catherine Boeglen; Stine Büchmann-Møller; Ming Sin Cheung; André Cordier; Christopher De Benedetto; Mark Deurinck; Moritz Frei; Pierre Moulin; Edward Oakeley; Olivier Grenet; Armelle Grevot; Robert Stull; Diethilde Theil; Jonathan G Moggs; Estelle Marrer; Philippe Couttet","Preclinical Safety, Novartis Institutes of Biomedical Research, Basel, Switzerland; Biomarker Development, Novartis Institute for Biomedical Research, Basel, Switzerland; Preclinical Safety, Novartis Institute of Biomedical Research, East Hanover, New Jersey, United States of America","Conceived and designed the experiments: CVS EM PC. Performed the experiments: CVS MM VD MW PS CDB MF CB. Analyzed the data: CVS FH MSC AC. Contributed reagents/materials/analysis tools: SBM EO RS AG. Wrote the paper: CVS PC EM. Supervised the study and experimental design: PC PM AC DT MD OG JGM. Reviewed and commented the manuscript: JGM.","All authors are employees of the Novartis Pharma AG. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","01","Caterina Vacchi-Suzzi","CVS",22,TRUE,3,8,4,3,TRUE,TRUE,FALSE,0,NA,FALSE
